Aastrom Biosciences Inc (NASDAQ:ASTM)

CAPS Rating: 2 out of 5

The regenerative medicine company engaged in clinical development of autologous cell products for the repair or regeneration of multiple human tissues, based on proprietary Tissue Repair Cell Technology.

Recs

0
Player Avatar pchop123 (76.56) Submitted: 8/31/2012 11:54:40 AM : Outperform Start Price: $1.70 ASTM Score: -3.63

Looking for upside now

Featured Broker Partners


Advertisement